Bigul

GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Approval for the Store Brand OTC Equivalent of Advil Dual Action Tablets
14-07-2023
Bigul

GRANULES INDIA LTD.-$ - 532482 - Granules India'S Gagillapur Facility Received EIR From The US FDA

Granules India''s Gagillapur facility received EIR from the US FDA
13-07-2023

Hot Stocks | Here's why you should bet on Granules India, Orient Electric for short term

It is advisable to secure profits at higher levels and avoid complacency until the indicators exit the overbought territory.
10-07-2023

Granules India gains 2% as USFDA inspection ends with no observation

The share touched a 52-week high of Rs 381.25 and a 52-week low of Rs 267.85 on 04 November, 2022 and 29 March, 2023, respectively.
03-07-2023
Bigul

Granules India completes FDA inspection in two facilities

The company said its facility at Jeedimetla (Hyderabad) also completed the US FDA's surveillance inspection
01-07-2023
Bigul

GRANULES INDIA LTD.-$ - 532482 - Granules India'S Unit IV Facility Located At Visakhapatnam Completed The US FDA Inspection

Granules India''s Unit IV facility located at Visakhapatnam completed the US FDA inspection
30-06-2023

Granules India falls after cyberattack erodes topline

On June 29, Granules India Ltd. reported a significant loss of revenue and profitability caused due to a cyber security breach attack incurred by the company last month.
30-06-2023

Paracetamol maker Granules India flags operations hit from cyber attack

Due to significant changes in its IT systems, the IT security incident caused a major disruption in its business operations, the Paracetamol maker said in an exchange filing
29-06-2023
Bigul

GRANULES INDIA LTD.-$ - 532482 - Update On IT Security Incident

Update on IT Security Incident
29-06-2023
Next Page
Close

Let's Open Free Demat Account